VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PCRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PCRXPacira BioSciences, Inc.
$25.82$1.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPCRXPrice History

PCRX logoPacira BioSciences, Inc. (PCRX) Stock Price History

Historical prices from 2011 to 2026

$25.82+0.23  (+0.90%)close Jul 7
Returns
1M
+12.9%
3M
+14.6%
YTD
+5.6%
1Y
+11.2%
3Y
-12.0%
5Y
-14.6%
ATH$121.95Feb 2015-78.8%
ATL$6.16Feb 2011pre-split
Avg Vol (50D)454K/ day
52-Week Range$18.80 — $27.64
LowCurrent: $25.82High

Loading 10-year price history...

PCRX Historical Performance

1 YearTotal Return
+11.2%
Price: +11.2%
3 YearsTotal Return
-31.9%
CAGR: -12.0%
Price: -31.9%
5 YearsTotal Return
-54.5%
CAGR: -14.6%
Price: -54.5%
YTD
+5.6%

PCRX Annual Returns

Year-by-year price performance · 2011–2026

Best+230.8%2013
Worst-57.3%2016
Up years9/16
2011+23.2%
2012+100.2%
2013+230.8%
2014+56.9%
2015-15.8%
2016-57.3%
2017+31.4%
2018-7.1%
2019+8.4%
2020+31.3%
2021+1.5%
2022-36.9%
2023-13.2%
2024-41.1%
2025+41.2%
2026-10.4%
2011 annual price return
+23.2%
2012 annual price return
+100.2%
2013 annual price return
+230.8%
2014 annual price return
+56.9%
2015 annual price return
-15.8%
2016 annual price return
-57.3%
2017 annual price return
+31.4%
2018 annual price return
-7.1%
2019 annual price return
+8.4%
2020 annual price return
+31.3%
2021 annual price return
+1.5%
2022 annual price return
-36.9%
2023 annual price return
-13.2%
2024 annual price return
-41.1%
2025 annual price return
+41.2%
2026 annual price return
-10.4%
LessMore
Alpha vs S&P 500
1Y-23.5%
3Y-35.6%
5Y-28.7%

Price returns only.

Download Historical Data

3,878 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

PCRX Stock Price Trajectory (2011–2026)

As of July 8, 2026, Pacira BioSciences, Inc. (PCRX) trades at $25.82, representing a +11.2% return over the past year. The stock has delivered a -54.5% total return over five years (-14.6% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $121.95 on February 25, 2015. From this peak, PCRX has corrected -78.8%, currently trading 10% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers PRGO (-58.2% 1Y), BHC (-28.5% 1Y), and SUPN (+50.7% 1Y), PCRX has underperformed the peer group average. Compare PCRX vs PRGO →

PCRX Historical Price Data · from 2011

Rows 1–50 of 3,878
Date Open High Low Close Volume Change %
2026-07-0725.8526.6425.3425.82446K+0.90%
2026-07-0625.2925.7125.0025.59286K+0.79%
2026-07-0225.1625.5124.4325.39365K+1.44%
2026-07-0125.7525.8524.5925.03541K-1.34%
2026-06-3026.0026.0024.6425.37453K+1.12%
2026-06-2924.7925.1924.6025.09347K-0.59%
2026-06-2624.2925.6224.2925.240+3.57%
2026-06-2523.9324.4923.8524.37359K+1.71%
2026-06-2423.7424.2023.7423.96384K+1.91%
2026-06-2323.2323.6422.9823.51370K+3.52%
2026-06-2222.4422.8422.0022.71657K+1.70%
2026-06-1822.7622.9522.1922.33762K-1.37%
2026-06-1722.7623.8022.5722.64341K-0.79%
2026-06-1622.9223.3522.5622.82422K+0.35%
2026-06-1523.5523.5522.6722.74304K-1.09%
2026-06-1223.5623.7122.9422.99366K-1.58%
2026-06-1123.5224.0323.3223.36342K-0.26%
2026-06-1023.5623.8123.1723.42256K+0.90%
2026-06-0923.0023.6523.0023.21396K+1.53%
2026-06-0822.7023.2022.5222.86378K+0.48%
2026-06-0522.9323.2122.6022.75375K+0.35%
2026-06-0422.2722.9922.2722.67470K+1.57%
2026-06-0322.2822.5322.0022.32210K+0.31%
2026-06-0222.9623.1622.2322.25259K-3.09%
2026-06-0123.2223.4122.7922.96354K-1.12%
2026-05-2923.6623.9723.1723.22406K-1.94%
2026-05-2823.8524.1423.2123.68208K-1.50%
2026-05-2725.1725.1723.8524.04291K-1.31%
2026-05-2623.3424.7022.8724.36613K+4.33%
2026-05-2223.5023.5023.2423.35852K-0.55%
2026-05-2122.9823.8622.4723.48382K+2.09%
2026-05-2022.3123.1021.9023.00514K+3.09%
2026-05-1922.4922.8722.1722.31412K-0.58%
2026-05-1822.4922.7722.2922.44290K-0.88%
2026-05-1523.6423.9422.6222.64434K-3.78%
2026-05-1423.1423.7122.7323.53357K+2.13%
2026-05-1322.7123.2522.4423.04389K+0.88%
2026-05-1223.1123.1122.3022.84580K+0.44%
2026-05-1123.3123.6822.4722.74653K-1.77%
2026-05-0823.8924.4123.0823.15498K-2.07%
2026-05-0723.8924.2123.1823.64515K-0.21%
2026-05-0624.9724.9723.6023.69521K-4.44%
2026-05-0524.9525.6024.7424.79203K+0.41%
2026-05-0424.3325.4824.3024.69753K+1.02%
2026-05-0126.8027.1323.4724.441.63M-4.12%
2026-04-3025.2026.2725.0325.491.03M+1.39%
2026-04-2925.2525.4924.9325.14377K-1.06%
2026-04-2825.7326.1425.2625.41378K-0.55%
2026-04-2724.0725.6824.0725.55466K+4.24%
2026-04-2425.3925.3924.2124.51490K-3.35%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

PCRX — Frequently Asked Questions

Quick answers to the most common questions about buying PCRX stock.

How has PCRX stock performed recently?

PCRX returned +11.2% over the past year, beating its 5-year annualized CAGR of -14.6%. The stock trades above its 200-day moving average, confirming the uptrend.

What is PCRX's all-time high price?

Pacira BioSciences, Inc. reached $121.95 on 2015-02-25. The 52-week high is $27.64. Current 1-year return of +11.2% places the stock closer to historical peaks.

Where can I download PCRX historical price data?

This page provides PCRX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2011-2026, downloadable in CSV format.

486 data points · sampled from 3,878